Ascendis Pharma AS Capital Reinvestment Ratio
Ascendis Pharma AS capital reinvestment ratio. Ascendis Pharma AS (A71) has a Capital Reinvestment Ratio of 0.05x as of December 2025, meaning it reinvests 0% of its operating cash flow (€73.40 Million) in capital expenditures (€3.39 Million). See free cash flow generation of Ascendis Pharma AS to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Ascendis Pharma AS (2025–2025)
Capital reinvestment ratio of Ascendis Pharma AS from 2025 to 2025. This chart tracks Ascendis Pharma AS's Capital Reinvestment Ratio across 1 annual periods. See financial agility of Ascendis Pharma AS to measure the company's free cash flow as a share of total liabilities.
Ascendis Pharma AS Capital Reinvestment Ratio by Year (2025–2025)
Ascendis Pharma AS capital reinvestment ratio by year from 2025 to 2025. For the full cash flow conversion analysis, see how efficiently does Ascendis Pharma AS generate cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | €53.90 Million | €8.48 Million | — |